1 Min Read
Dec 21 (Reuters) - Sangui Biotech International Inc :
* SastoMed enters into sales agreement for Turkey
* Granulox receives product approval in Kuwait Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.